Skip to main content
Caplight Logo









Enalees

Enalees

Private
FranceHealthcare & Life Scienceshttps://www.enalees.com/en/

Last Round

Series A

Jun 27, 2024

Total Funding Raised

$18.7M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Enalees is a biotechnology company that develops, manufactures, and distributes rapid PCR tests for detecting infectious diseases in animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

veterinary diagnosticsPOC testingpoint-of-care diagnosticsLAMP technologymolecular diagnosticsveterinary biotechVetTechanimal healthLoop-mediated isothermal amplificationisothermal amplificationinfectious disease testingcompanion animal diagnosticsportable analyzerlivestock diagnosticsdiagnostic consumablesequine diagnosticsrazor and blade modellyophilization services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enalees Comparables

Compare Enalees with similar companies based on industry and business-model similarity.

Enalees comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GeneReach Biotechnology Corp.
74%
Vimian Group
71%
IDEXX Laboratories, Inc.
67%

Enalees Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 27, 2024
GrantOct 11, 2022
GrantNov 20, 2020
CrowdfundingDec 15, 2018
SeedMay 1, 2016

Key People

Founding team and executive leadership

Laurent Thiery

Founder and CEO

Founding Team

Enalees Investors

Notable investors and investment history

Enalees investors
InvestorRounds
France 2030Grant
Région Île-de-FranceGrant
BpifranceSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 33% MoM, reaching 2.2K.

  • Jan 21, 2026

    Monthly visitors increased 159% MoM, reaching 5K.

Enalees Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enalees Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enalees's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Employee Range42
Year Founded2015
Last FundingJun 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?